The multinational company has confirmed that it is working on a vaccine, describing its efforts as "in the initial phase and still ongoing." And the markets have reacted with enthusiasm.
AI Brief
Your highlights
By Irene Maria Scalise
(Reuters)
The multinational company has confirmed that it is working on a vaccine, describing its efforts as "in the initial and ongoing phase." And the markets have reacted with enthusiasm.